2008
DOI: 10.4161/auto.6259
|View full text |Cite
|
Sign up to set email alerts
|

Neurodegenerative lysosomal disorders: A continuum from development to late age

Abstract: Neuronal survival requires continuous lysosomal turnover of cellular constituents delivered by autophagy and endocytosis. Primary lysosomal dysfunction in inherited congenital "lysosomal storage" disorders is well known to cause severe neurodegenerative phenotypes associated with accumulations of lysosomes and autophagic vacuoles (AVs). Recently, the number of inherited adult-onset neurodegenerative diseases caused by proteins that regulate protein sorting and degradation within the endocytic and autophagic pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
267
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 330 publications
(279 citation statements)
references
References 117 publications
(105 reference statements)
9
267
0
Order By: Relevance
“…Indeed, trypsinogen activation has been recently reported (78) in endocytic vacuoles in response to CCK hyperstimulation of acinar cells. A number of characteristics of pancreatitis are similar to those observed in lysosomal disorders (which are mostly caused by mutations that inactivate lysosomal hydrolases or affect their delivery to lysosomes)-such as block of autophagy, impaired maturation of cathepsins, decreased protein degradation, cell vacuolation and death, and the inflammatory response (59). Thus, our findings indicate that acute pancreatitis has features of a lysosomal disease, which should be taken into consideration in designing strategies to treat or mitigate pancreatitis.…”
Section: Lysosomal Dysfunction and Impaired Autophagy In Pancreatitismentioning
confidence: 58%
See 2 more Smart Citations
“…Indeed, trypsinogen activation has been recently reported (78) in endocytic vacuoles in response to CCK hyperstimulation of acinar cells. A number of characteristics of pancreatitis are similar to those observed in lysosomal disorders (which are mostly caused by mutations that inactivate lysosomal hydrolases or affect their delivery to lysosomes)-such as block of autophagy, impaired maturation of cathepsins, decreased protein degradation, cell vacuolation and death, and the inflammatory response (59). Thus, our findings indicate that acute pancreatitis has features of a lysosomal disease, which should be taken into consideration in designing strategies to treat or mitigate pancreatitis.…”
Section: Lysosomal Dysfunction and Impaired Autophagy In Pancreatitismentioning
confidence: 58%
“…Physiological autophagy triggers efficient turnover of autophagosomes into autolysosomes and stimulates protein degradation. Many diseases are associated with impaired autophagic flux, which is manifest, first of all, by vacuole accumulation (47,59). Impairment or retardation of the autophagic flux could be caused by a defective fusion of autophagosomes with lysosomes or by inefficient degradation of cellular constituents in autolysosomes (Fig.…”
Section: Lysosomal Dysfunction and Impaired Autophagy In Pancreatitismentioning
confidence: 99%
See 1 more Smart Citation
“…Aging brains exhibit reduced lysosomal function and, in neurodegenerative diseases, increased accumulation of macroautophagic vesicles has been observed in postmortem patient brains compared to normal controls. [4][5][6][7] Because of the importance of macroautophagy and lysosomal activities to cellular functions, it is expected that the two…”
Section: Introductionmentioning
confidence: 99%
“…Macroautophagy (hereafter, autophagy) has been implicated in bulk degradation of pathologic aggregates, such as the polyglutamine-expanded huntingtin inclusions observed in Huntington disease (13). ALP is a vital cellular process, and impairment of the ALP can lead to neurodegeneration, as demonstrated in animal models that are deficient in genes coding for autophagy proteins in neuronal tissue (14,15) and in human neurodegenerative lysosomal storage diseases (16,17).…”
mentioning
confidence: 99%